SARAH SARTAIN to Adolescent
This is a "connection" page, showing publications SARAH SARTAIN has written about Adolescent.
Connection Strength
0.314
-
Hospital acquired venous thromboembolism in children with sickle cell disease. Pediatr Hematol Oncol. 2024 Oct; 41(7):459-469.
Score: 0.065
-
COVID-19 vaccine (mRNA BNT162b2) and COVID-19 infection-induced thrombotic thrombocytopenic purpura in adolescents. Pediatr Blood Cancer. 2022 06; 69(6):e29681.
Score: 0.056
-
The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy. Pediatr Blood Cancer. 2020 03; 67(3):e28070.
Score: 0.048
-
Therapeutic Plasma Exchange does not Improve Renal Function in Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: An Institutional Experience. Biol Blood Marrow Transplant. 2019 01; 25(1):157-162.
Score: 0.044
-
The Pathology of Pulmonary Disease After Pediatric Hematopoietic Stem Cell Transplantation. Am J Surg Pathol. 2024 Oct 01; 48(10):1201-1214.
Score: 0.016
-
Prospective Clinical and Biomarker Validation of the American Society for Transplantation and Cellular Therapy Consensus Definition for Transplantation-Associated Thrombotic Microangiopathy. Transplant Cell Ther. 2023 Nov; 29(11):685.e1-685.e7.
Score: 0.015
-
Adolescent acquired thrombotic thrombocytopenic purpura: An analysis of the Pediatric Health Information System database. Thromb Res. 2023 02; 222:63-67.
Score: 0.015
-
Practical considerations and consensus opinion for children's hospital-based inpatient hemostasis and thrombosis (HAT) consultative services: Communication from the ISTH SSC Subcommittee on Pediatric/Neonatal Thrombosis and Hemostasis. J Thromb Haemost. 2022 09; 20(9):2151-2158.
Score: 0.014
-
Pulmonary embolism in pediatric and adolescent patients with COVID-19 infection during the SARS-CoV-2 delta wave. Pediatr Blood Cancer. 2022 08; 69(8):e29721.
Score: 0.014
-
Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C. Blood. 2021 07 15; 138(2):190-198.
Score: 0.013
-
Clinical characteristics and outcomes of combined thrombolysis and anticoagulation for pediatric and young adult lower extremity and inferior vena cava thrombosis. Pediatr Hematol Oncol. 2021 Sep; 38(6):528-542.
Score: 0.013